ArticleFrontiers in nutrition2021

MRI-Based Radiomic Signature Identifying Secondary Loss of Response to Infliximab in Crohn's Disease.

Jing Feng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.